Mon, Jan 26, 2015, 12:40 PM EST - U.S. Markets close in 3 hrs 20 mins


% | $
Quotes you view appear here for quick access.

Abbott Laboratories Message Board

  • askindoc Oct 17, 2012 4:08 PM Flag

    No buyers...seemed overdone to me!

    Hammered today

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Study of Abbott,Reata Kidney-Disease Drug Stopped Over Safety Concerns 10/18 09:36 AM

      Abbott Laboratories (ABT:$65.16,00$-3.88,00-5.62%) said Thursday a clinical trial of an experimental treatment for kidney disease was discontinued due to safety concerns including an excessive death rate among the drug's users.
      Abbott was informed of the trial's discontinuation Wednesday by its partner for the drug, Reata Pharmaceuticals Inc., Abbott said in a filing with the Securities and Exchange Commission. Reata confirmed the news in a separate statement.
      Abbott licensed rights for the drug, bardoxolone, outside the U.S. from Reata in 2010.
      According to Abbott, Reata discontinued a late-stage, or Phase 3, study evaluating bardoxolone in patients with advanced chronic kidney disease and Type 2 diabetes.
      The discontinuation was based on a recommendation by the study's independent data monitoring committee, due to "excess serious adverse events and mortality in the bardoxolone methyl arm." The drug was being compared with a placebo, according to
      Abbott said regulatory agencies have been notified, and study sites and study participants are being informed.
      The companies will review the data to determine whether there is an appropriate path forward for development of the drug in chronic kidney disease or other potential uses.

      (END) Dow Jones Newswires

    • Me, yesterday :D

      Sentiment: Buy

    • I heard Cramer say buy ABT ahead of split so hopefully he'll mention it on his show tonight
      and say buy, buy, buy. I just bought today, haven't traded this in a long time!!!

      Sentiment: Strong Buy

43.8945+0.0345(+0.08%)12:40 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.